Healthcare · Healthcare Equipment & Supplies
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
Source: Wikipedia
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #None of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | HDFC MUTUAL FUND | Bulk | Buy | 2,300,000 | 1315.0000 | BSE |
| 30 Sep 2026 | BUSINESS EXCELLENCE TRUST III | Bulk | Sell | 2,328,996 | 1315.0100 | BSE |
| 16 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Buy | 590,709 | 1288.1400 | NSE |
| 16 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Sell | 591,823 | 1288.6000 | NSE |
| 11 Sep 2026 | QE SECURITIES LLP | Bulk | Buy | 1,210,738 | 1542.3600 | NSE |
| 11 Sep 2026 | QE SECURITIES LLP | Bulk | Sell | 1,188,458 | 1552.0200 | NSE |
| 11 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Sell | 753,493 | 1545.8800 | NSE |
| 11 Sep 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | Buy | 753,493 | 1544.9700 | NSE |
| 11 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Sell | 1,228,332 | 1566.9400 | NSE |
| 11 Sep 2026 | JUNOMONETA FINSOL PRIVATE LIMITED | Bulk | Buy | 1,233,175 | 1565.7900 | NSE |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 5 Sep 2026 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | Insider Trading / SAST | Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 1 Oct 2026 | Insider Trading / SAST | Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 28 Sep 2026 | Insider Trading / SAST | Molbio Diagnostics Ltd - 544866 - Closure of Trading Window |
| 28 Sep 2026 | Trading Window | Molbio Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 25 Sep 2026 | Outcome of Board Meeting | Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27. |
| 25 Sep 2026 | Insider Trading / SAST | Molbio Diagnostics Ltd - 544866 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 25 Sep 2026 | Insider Trading / SAST | Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 25 Sep 2026 | Others | Molbio Diagnostics Ltd - 544866 - Board Meeting Outcome for Re-Appointment Of Cost Auditor Of The Company For FY 2026-27. |
| 17 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Molbio Diagnostics Limited has informed the Exchange about Schedule of meet to be held on Tuesday, September 22, 2026 at 11.00 A.M.(IST) onwards. |
| 12 Sep 2026 | Company Update | Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
